Source: American journal of cancer research. Unidade: FM
Subjects: CARCINOMA DE CÉLULAS ESCAMOSAS, INIBIDORES DE ENZIMAS, CÉLULAS-TRONCO, QUIMIOTERAPIA
ABNT
SILVA, Luan Cesar et al. Repurposing NF kappa B and HDAC inhibitors to individually target cancer stem cells and non-cancer stem cells from mucoepidermoid carcinomas. American journal of cancer research, v. 13, n. 4, p. 1547-1559, 2023Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/54550. Acesso em: 28 ago. 2024.APA
Silva, L. C., Borgato, G. B., Wagner, V. P., Martins, M. D., Santos-Silva, A. R. dos, Castro Junior, G. de, et al. (2023). Repurposing NF kappa B and HDAC inhibitors to individually target cancer stem cells and non-cancer stem cells from mucoepidermoid carcinomas. American journal of cancer research, 13( 4), 1547-1559. Recuperado de https://observatorio.fm.usp.br/handle/OPI/54550NLM
Silva LC, Borgato GB, Wagner VP, Martins MD, Santos-Silva AR dos, Castro Junior G de, Kowalski LP, Squarize CH, Vargas PA, Castilho RM. Repurposing NF kappa B and HDAC inhibitors to individually target cancer stem cells and non-cancer stem cells from mucoepidermoid carcinomas [Internet]. American journal of cancer research. 2023 ; 13( 4): 1547-1559.[citado 2024 ago. 28 ] Available from: https://observatorio.fm.usp.br/handle/OPI/54550Vancouver
Silva LC, Borgato GB, Wagner VP, Martins MD, Santos-Silva AR dos, Castro Junior G de, Kowalski LP, Squarize CH, Vargas PA, Castilho RM. Repurposing NF kappa B and HDAC inhibitors to individually target cancer stem cells and non-cancer stem cells from mucoepidermoid carcinomas [Internet]. American journal of cancer research. 2023 ; 13( 4): 1547-1559.[citado 2024 ago. 28 ] Available from: https://observatorio.fm.usp.br/handle/OPI/54550